Skip to main content
Log in

First-line voriconazole best option for invasive aspergillosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Ament AJHA, Hübben MWA, Verweij PE, De Groot R, Warris A, Donnelly JP, van 't Wout J, Severens JL.Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach. Journal of Antimicrobial Chemotherapy 60: 385-393, No. 2, Aug 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

First-line voriconazole best option for invasive aspergillosis. Pharmacoecon. Outcomes News 538, 3 (2007). https://doi.org/10.2165/00151234-200705380-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705380-00005

Keywords

Navigation